Notable features of our strategy include (a) first enantioselective electrochemical organometallic C-H activation in continuous flow, (b) allenes for the synthesis of atropoisomers, (c) cobalta-electrocatalytic access to C-N axially chiral anilides via C-H annulation, (d) mild reaction conditions for high enantioselectivity, (e) late-stage functionalization of bioactive compounds and drug molecules, (f) ease of scale-up, and (g) the assembly of a variety of P-stereogenic compounds.